Figure 2
From: Kefir metabolites in a fly model for Alzheimer’s disease
(a) Survival rate of non-treated, kefir, and milk-treated AD-like flies (n ≥ 90 in each group). The statistical significance is indicated as *** for P < 0.001 and **** for P < 0.0001 (log-rank, Mantel–Cox test). (b) AD-like flies climbing ability after kefir and milk treatment at 5 and 10 days after treatment (d.a.t.). Kefir-treated flies performed better than control at both tested ages, and better than milk-treated flies at 5 d.a.t.. At 10 d.a.t., flies treated with milk or kefir showed an equivalent performance. Data are shown as the mean ± S.E.M. n ≥ 90 in each group. (c) Neurodegenerative index of non-treated (control) and kefir treated AD-like flies (n = 10, 10 days after treatment). The statistical significance is indicated as ** for P < 0.01, *** for P < 0.001, **** for P < 0.0001 and (Unpaired two-tailed t-test).
